These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 8067901)
1. Comparison of DNA reactivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver. Montandon F; Williams GM Arch Toxicol; 1994; 68(4):272-5. PubMed ID: 8067901 [TBL] [Abstract][Full Text] [Related]
2. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Hard GC; Iatropoulos MJ; Jordan K; Radi L; Kaltenberg OP; Imondi AR; Williams GM Cancer Res; 1993 Oct; 53(19):4534-41. PubMed ID: 8402624 [TBL] [Abstract][Full Text] [Related]
3. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro. Hemminki K; Widlak P; Hou SM Carcinogenesis; 1995 Jul; 16(7):1661-4. PubMed ID: 7614704 [TBL] [Abstract][Full Text] [Related]
4. 17beta-estradiol, diethylstilbestrol, tamoxifen, toremifene and ICI 164,384 induce morphological transformation and aneuploidy in cultured Syrian hamster embryo cells. Tsutsui T; Taguchi S; Tanaka Y; Barrett JC Int J Cancer; 1997 Jan; 70(2):188-93. PubMed ID: 9009159 [TBL] [Abstract][Full Text] [Related]
5. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene. Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810 [TBL] [Abstract][Full Text] [Related]
6. DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver. Hashiba M; Kasahara T; Kim SY; Shibutani S; Degawa M Cancer Sci; 2006 Jun; 97(6):468-77. PubMed ID: 16734724 [TBL] [Abstract][Full Text] [Related]
7. DNA adduct formation by tamoxifen and structurally-related compounds in rat liver. Rajaniemi H; Mäntylä E; Hemminki K Chem Biol Interact; 1998 May; 113(2):145-59. PubMed ID: 9717515 [TBL] [Abstract][Full Text] [Related]
8. Initiating activity of the anti-estrogen tamoxifen, but not toremifene in rat liver. Williams GM; Iatropoulos MJ; Karlsson S Carcinogenesis; 1997 Nov; 18(11):2247-53. PubMed ID: 9395228 [TBL] [Abstract][Full Text] [Related]
9. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene. Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033 [TBL] [Abstract][Full Text] [Related]
10. Clastogenic and aneugenic effects of tamoxifen and some of its analogues in hepatocytes from dosed rats and in human lymphoblastoid cells transfected with human P450 cDNAs (MCL-5 cells). Styles JA; Davies A; Davies R; White IN; Smith LL Carcinogenesis; 1997 Feb; 18(2):303-13. PubMed ID: 9054622 [TBL] [Abstract][Full Text] [Related]
11. Delayed effects of tamoxifen in hepatocarcinogenesis-resistant Fischer 344 rats as compared with susceptible strains. Stanley LA; Carthew P; Davies R; Higginson F; Martin E; Styles JA Cancer Lett; 2001 Sep; 171(1):27-35. PubMed ID: 11485825 [TBL] [Abstract][Full Text] [Related]
12. Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley rats. Sargent LM; Dragan YP; Sattler C; Bahnub N; Sattler G; Martin P; Cisneros A; Mann J; Thorgeirsson S; Jordan VC; Pitot HC Carcinogenesis; 1996 May; 17(5):1051-6. PubMed ID: 8640912 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and reactivity of potential toxic metabolites of tamoxifen analogues: droloxifene and toremifene o-quinones. Yao D; Zhang F; Yu L; Yang Y; van Breemen RB; Bolton JL Chem Res Toxicol; 2001 Dec; 14(12):1643-53. PubMed ID: 11743747 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats. Dragan VP; Vaughan J; Jordan VC; Pitot HC Carcinogenesis; 1995 Nov; 16(11):2733-41. PubMed ID: 7586193 [TBL] [Abstract][Full Text] [Related]
15. Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in the rat. Ahotupa M; Hirsimäki P; Pärssinen R; Mäntylä E Carcinogenesis; 1994 May; 15(5):863-8. PubMed ID: 8200088 [TBL] [Abstract][Full Text] [Related]
16. The proliferation in uterine compartments of intact rats of two different strains exposed to high doses of tamoxifen or toremifene. Karlsson S; Iatropoulos MJ; Williams GM; Kangas L; Nieminen L Toxicol Pathol; 1998; 26(6):759-68. PubMed ID: 9864093 [TBL] [Abstract][Full Text] [Related]
17. Comparisons of the binding of [14C]radiolabelled tamoxifen or toremifene to rat DNA using accelerator mass spectrometry. White IN; Martin EA; Mauthe RJ; Vogel JS; Turteltaub KW; Smith LL Chem Biol Interact; 1997 Sep; 106(2):149-60. PubMed ID: 9366900 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis. Kärki A; Mäntylä E; Hirsimäki Y; Karlsson S; Toikkanen S; Hirsimäki P Arch Toxicol; 2000 Jul; 74(4-5):249-56. PubMed ID: 10959800 [TBL] [Abstract][Full Text] [Related]
19. Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy. Buzdar AU; Hortobagyi GN J Clin Oncol; 1998 Jan; 16(1):348-53. PubMed ID: 9440763 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of lower genotoxicity of toremifene compared with tamoxifen. Shibutani S; Ravindernath A; Terashima I; Suzuki N; Laxmi YR; Kanno Y; Suzuki M; Apak TI; Sheng JJ; Duffel MW Cancer Res; 2001 May; 61(10):3925-31. PubMed ID: 11358807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]